From: Long-term prognostic significance of rising PSA levels following radiotherapy for localized prostate cancer – focus on overall survival
Factor
Hazard ratio
95% Confidence interval
p-value
Nadir <0.17 ng/ml
AHT
2.6
1.5–4.4
p < 0.01
Treatment
LDR-BT vs. EBRT
6.9
3.8–12.9
HDR-BT + EBRT vs. EBRT
3.4
1.8–6.4